Multidisciplinary care is an ideal way to management non-alcoholic fatty liver disease (NAFLD) because it is a complex disease associated with numerous comorbidities and necessitating lifestyle changes.
The complexity of non-alcoholic fatty liver disease (NALFD), associated with metabolic disease, cardiac and diabetic complications, and lifestyle factors, makes it ideal for multidisciplinary care. According to a study published in Hepatology, multidisciplinary care can help prevent progression, which is key as NAFLD becomes more prevalent.
Researchers reviewed current models of multidisciplinary care teams and introduced a framework to build a comprehensive NAFLD program. Multidisciplinary clinics (MDCs) are already used in oncology, type 2 diabetes, and women’s health to improve patient satisfaction, as well as clinical and financial outcomes.
“While traditional health care delivery models consist of physicians assessing patients independently, MDCs promote coordinated care by integrating consultations and centralizing into a single clinic space,” the authors explained.
Although data are scarce on NAFLD multidisciplinary care, there are studies on MDCs for the comorbidities associated with NAFLD:
However, for NAFLD, few guidelines on multidisciplinary care have been published. The Division of Gastroenterology and Hepatology at Weill Cornell Medicine developed the Innovation Center for Health and Nutrition in Gastroenterology (ICHANGE), which targets patients with NAFLD and disease progression.
“ICHANGE employs concepts previously published in successful MDC models and can guide development of other NAFLD MDCs,” the authors wrote.
ICHANGE is led by a hepatologist, but it utilizes an endocrinologist, cardiologist, and dietitian to manage the associated comorbidities of NAFLD. The care team also includes gastroenterologists, endobariatricians, bariatric providers, and advanced practice providers, with a nurse navigator as the point of contact.
The nurse navigator introduces the patient to the program and the care team. All patients initially meet with a hepatologist and a registered dietitian, and a referral algorithm is used to schedule appointments with the ICHANGE providers. Patients with multiple risk factors for cardiovascular disease or risk-enhancing factors are offered a consultation with a preventive cardiologist.
During the initial consultation, the providers evaluate the associated comorbidities, assess stage of liver disease, review lifestyle practices, and formulate a treatment plan. Patients are stratified based on their fibrosis risk, which then determines frequency of follow-up and use of pharmacotherapy.
Patients receive diet and lifestyle counseling, exercise recommendations, and personalized meal planning. The follow-up occurs at 1- to 6-month intervals and focuses on weight and body composition tracking, food and activity review, maintenance of weight loss, disease monitoring, and treatment optimization.
The authors noted that the MDC streamlines the referral process and allows for specialty care to be provided in one setting. ICHANGE utilized concepts from other successful MDCs, highlighting that MDC concepts can be adapted according to the health care setting, they added.
“As NAFLD MDCs become more common, additional prospective evidence will guide long term efficacy and further define best practices,” the authors concluded.
Reference
Kumar S, Wong R, Newberry C, Yeung M, Peña JM, Sharaiha RZ. Multi-disciplinary clinic models: a paradigm of care for management of non-alcoholic fatty liver disease (NAFLD). Hepatology. Published online July 29, 2021. doi:10.1002/hep.32081
SABCS 2023 Sessions Touch on "Every Aspect of Breast Cancer"
December 4th 2023The 46th annual San Antonio Breast Cancer Symposium will take place December 5-9, with new and experienced attendees able to choose and learn from a schedule overflowing with the latest developments in breast cancer science and research.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
NK Cell Therapy SNK01 Improves Cognitive Function in Alzheimer Disease for up to 11 Weeks
December 3rd 2023Among 10 patients evaluated, compared with their baseline at 1 week after receiving their final dose in the trial, 30% demonstrated clinical improvement on the Alzheimer’s disease composite score.
Read More
Health Equity and Access Weekly Roundup: December 2, 2023
December 2nd 2023The Center on Health Equity and Access highlights the most recent updates in the realm of health equity, including news, research findings, and initiatives focused on mitigating health care disparities and enhancing overall access to quality care.
Read More